Form D · Biotechnology
ESCAPE Bio, Inc.
South San Francisco, CA · CIK 0001651573
Offering snapshot reported Sep 28, 2020 · SEC filing
- Reported sold
- $73M Offering amount: $73M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 14, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 28, 2020 | Initial | $73,000,000 | No comparison | 29 | SEC filing |
| Jul 29, 2019 | Initial | $31,073,380 | No comparison | 22 | SEC filing |
| Oct 11, 2018 | Amendment | $63,002,700 | $17,000,000vs Jun 2, 2017 | 31 | SEC filing |
| Jun 2, 2017 | Amendment | $46,002,700 | $26,000,000vs Aug 31, 2015 | 32 | SEC filing |
| Aug 31, 2015 | Initial | $20,002,700 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-376482
Source: Form D, filed Sep 28, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carrolee Barlow | Executive |
| Laura Brass | Director |
| Leon Chen | Director, Executive |
| Giovanni Ferarra | Director |
| Giovanni Ferrara | Director |
| Markus Goebel | Director |
| Perry Karsen | Director |
| Judith Li | Director |
| Peter Moldt | Director |
| Anthony Rimac | Executive |
| Eric Shiozaki | Director |
| Julie Anne Smith | Director, Executive |
| Peter Thompson | Director |
| R Sanders Williams | Director |
| R. Sanders Williams | Director |
| R. Sanders Williams | Director |
| Paul Wren | Executive |
| Asish Xavier | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4000 Shoreline Ct, Ste 400
South San Francisco, CA, 94080
South San Francisco, CA, 94080